Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition

被引:12
作者
Iwasaki, Kenta [1 ]
Miwa, Yuko [1 ]
Uchida, Kazuharu [1 ]
Kodera, Yasuhiro [2 ]
Kobayashi, Takaaki [3 ]
机构
[1] Aichi Med Univ, Sch Med, Dept Kidney Dis & Transplant Immunol, Nagakute, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi, Japan
[3] Aichi Med Univ, Sch Med, Dept Renal Transplant Surg, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
Kidney transplantation; ABO-incompatibility; Accommodation; HLA-DR expression; Chronic antibody-mediated rejection; DONOR-SPECIFIC ANTIBODIES; CLASS-I ANTIBODY; KIDNEY-TRANSPLANTATION; MEDIATED REJECTION; ACCOMMODATION; SPLENECTOMY; COMPLEMENT; RITUXIMAB; INCREASE; RISK;
D O I
10.1016/j.trim.2016.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Donor-specific antibody (DSA), particularly against HLA class II, is a major cause of chronic antibody-mediated rejection (CAMR) after transplantation, although ABO-incompatible kidney transplantation has recently demonstrated favorable graft outcomes. The condition of no injury even in the presence of anti-donor antibody has been referred to as "accommodation", which would be one of the key factors for successful long-term graft survival. The purpose of this study was to analyze the beneficial effect of anti-blood group A/B antibody ligation on endothelial cells against HLA-DR antibody-mediated, complement-dependent cytotoxicity (CDC). Blood group A/Bexpressing endothelial cells EA.hy926 or Human Umbilical Vein Endothelia Cells (HUVEC) were incubated with IFN gamma in the presence or absence of anti-blood group A/B antibody or mTOR inhibitor (mTOR-i) for 48 h. The effects on signaling pathway, HLA expression, complement regulatory factors, and CDC were investigated. Expression of HLA-DR on EA.hy926 or HUVEC were successfully elicited by IFNI, treatment, although little or no expression was observed in quiescent cells. Pre-incubation with anti-blood group A/B antibody had resistance to HLA-DR antibody-mediated CDC against IFN gamma-treated cells in a concentration-dependent manner. This finding was ascribed to decreased expression of HLA-DR by post-translational regulation and increased expression of CD55/59, which was related to ERIC and mTOR pathway inhibition. mTOR-i also inhibited HLA-DR expression by itself. Furthermore, the combination of mTOR-I and anti-blood group A/B ligation had an additive effect in preventing HLA-DR antibody-mediated CDC. Anti-blood group A/B antibody might play a preventive role in CAMR. Inhibition of the ERIC and mTOR pathways may contribute to the development of a novel treatment in the maintenance period after transplantation. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 39 条
[1]   Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation [J].
Ashimine, Satoshi ;
Watarai, Yoshihiko ;
Yamamoto, Takayuki ;
Hiramitsu, Takahisa ;
Tsujita, Makoto ;
Nanmoku, Koji ;
Goto, Norihiko ;
Takeda, Asami ;
Katayama, Akio ;
Uchida, Kazuharu ;
Kobayashi, Takaaki .
KIDNEY INTERNATIONAL, 2014, 85 (02) :425-430
[2]   Role of Anti-MHC Class I Antibody in Facilitating Transplant Accommodation [J].
Atz, Mary E. ;
Reed, Elaine F. .
CRITICAL REVIEWS IN IMMUNOLOGY, 2008, 28 (06) :485-511
[3]  
Cornell L.D., 2008, ANN REV PATHOL MECH, V3
[4]   Expression of complement regulatory proteins in accommodated xenografts induced by anti-α-Gal IgG1 in a rat-to-mouse model [J].
Ding, J. Wen ;
Zhou, T. ;
Ma, L. ;
Yin, D. ;
Shen, J. ;
Ding, C. P. Y. ;
Tang, I. Y. ;
Byrne, G. W. ;
Chong, A. S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) :32-40
[5]   Successful ABO-Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression [J].
Flint, S. M. ;
Walker, R. G. ;
Hogan, C. ;
Haeusler, M. N. ;
Robertson, A. ;
Francis, D. M. A. ;
Millar, R. ;
Finlay, M. ;
Landgren, A. ;
Cohney, S. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (05) :1016-1024
[6]  
Fulcami N., 2012, TRANSPLANTATION, V93
[7]   Immune response, accommodation, and tolerance to transplantation carbohydrate antigens [J].
Galili, U .
TRANSPLANTATION, 2004, 78 (08) :1093-1098
[8]   Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection [J].
Gupta, Aditi ;
Murillo, Daniel ;
Yarlagadda, Sri G. ;
Wang, Connie J. ;
Nawabi, Atta ;
Schmitt, Timothy ;
Brimacombe, Michael ;
Bryan, Christopher F. .
TRANSPLANT IMMUNOLOGY, 2016, 37 :18-22
[9]   mTORC1 signaling controls multiple steps in ribosome biogenesis [J].
Iadevaia, Valentina ;
Liu, Rui ;
Proud, Christopher G. .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 36 :113-120
[10]  
Iwasaki K., 2010, BIOCH BIOPHYS RES CO, V391